Skip to main content
. Author manuscript; available in PMC: 2019 May 15.
Published in final edited form as: Neuropharmacology. 2017 Oct 28;134(Pt B):259–271. doi: 10.1016/j.neuropharm.2017.10.034

Table 2.

A comparison of Ktrans values in controls across different research groups. The missing values were not reported in the studies reviewed.

Groups Study Controls Ktrans (×10−3 min−1)
WM GM
Backes (van de Haar et al., 2017) 0.070±0.06 0.008±0.076(CGM)
(Zhang et al., 2017) 1.05±0.05 1.49±0.07(CGM), 1.11±0.06(DGM)
(van de Haar et al., 2016a) 0.070±0.06 0.017±0.08
(van de Haar et al., 2016b) 0.18±0.13
Zlokovic (Barnes et al., 2016) 2.25±0.25 3±1
(Montagne et al., 2015) 2.19±0.18 0.81±0.17(Thalamus)
Rosenberg (Taheri et al., 2011a) 1.5±0.5
(Taheri et al., 2011b) 1.8±0.15

WM, White Matter; GM, Gray Matter; CGM, Cortical Gray Matter; DGM, Deep Gray Matter